Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
24.24
-0.91 (-3.62%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Azenta Revenue
Azenta had revenue of $148.64M in the quarter ending December 31, 2025, with 0.82% growth. This brings the company's revenue in the last twelve months to $595.03M, up 2.74% year-over-year. In the fiscal year ending September 30, 2025, Azenta had annual revenue of $593.82M with 3.55% growth.
Revenue (ttm)
$595.03M
Revenue Growth
+2.74%
P/S Ratio
1.88
Revenue / Employee
$198,342
Employees
3,000
Market Cap
1.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 593.82M | 20.37M | 3.55% |
| Sep 30, 2024 | 573.45M | 21.96M | 3.98% |
| Sep 30, 2023 | 551.49M | -4.01M | -0.72% |
| Sep 30, 2022 | 555.50M | 41.80M | 8.14% |
| Sep 30, 2021 | 513.70M | 125.17M | 32.21% |
| Sep 30, 2020 | Pro | Pro | Pro |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTSPLY SIRONA | 3.68B |
| Embecta | 1.08B |
| AtriCure | 534.53M |
| LeMaitre Vascular | 249.60M |
| STAAR Surgical Company | 239.44M |
| BioLife Solutions | 96.21M |
| Kestra Medical Technologies | 83.72M |
| Alamar Biosciences | 74.21M |
AZTA News
- 21 days ago - Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution - PRNewsWire
- 7 weeks ago - Azenta Transcript: M&A announcement - Transcripts
- 7 weeks ago - Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities - PRNewsWire
- 2 months ago - Azenta Transcript: 47th Annual Raymond James Institutional Investor Conference - Transcripts
- 2 months ago - Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference - PRNewsWire
- 2 months ago - Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure - PRNewsWire
- 2 months ago - Azenta Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025 - PRNewsWire